Stephen Farr

Stephen James Farr was the founder of Zogenix, Inc. (2006), holding the title of President & Chief Executive Officer.
Current jobs include Chairman & Chief Executive Officer at Regel Therapeutics Inc. (2024), Chairman at Cerebral Therapeutics, Inc. (2020), Director at ICVRx LLC, Director at SteadyMed Therapeutics, Inc. (2012), Director at Zogenix International Ltd. (2014), Director at Zogenix Europe Ltd., Director at Flow Pharma, Inc., Director at Oscillari LLC, Director at Tevard Biosciences, Inc., Director at Mahzi Therapeutics, Inc., and Member at Royal Pharmaceutical Society of Great Britain.
Former jobs include Scientific Director at Novo Nordisk A, Independent Director at SteadyMed Ltd. (2012-2018), Professor at Welsh School of Pharmacy (1986-1994), and Chief Scientific Officer & Senior Vice President at Aradigm Corp.
(1986-1995).
Education includes a doctorate from The University of Wales and an undergraduate degree from De Montfort University.